Global bio-based polymers are expected to grow at a compound annual rate of 4% by 2023
Time of Update: 2020-11-19
The capacity and production of bio-based polymers will continue to grow, with a compound annual growth rate of about 4% expected by 2023, almost equal to the growth rate of fossil-based polymers and plastics.
Eglin Pharmaceuticals' new oral drug EG-001 for the treatment of idiotic interstitiotic pneumonia
Time of Update: 2020-10-29
's mission is to "focus on clinical needs and reach patients around the world", focusing on the development of innovative drugs in the areas of autoimmune, tumor immunity, and chronic diseases.
Eglin Pharmaceuticals' oral drug EG-009 for the treatment of neo-coronavirus pneumonia has been officially approved by the FDA for Phase I clinical trials.
Time of Update: 2020-10-20
EG-009 research and development will bring new hope to reduce the mortality rate of patients with neo-crown pneumonia at a time when the global epidemic of new coronary pneumonia continues.
Eglin EG-009 has been approved by the FDA to enter phase 1 clinical trials to treat new coronary pneumonia.
Time of Update: 2020-10-06
Shenzhen Eglin Pharmaceutical Co., Ltd. announced on September 23, 2020 U.S. Eastern Time, the U.S. FDA officially approved the company for the treatment of neo-coronavirus pneumonia oral capsule EG-009 clinical first phase application.
Diabetologia: What was the time trend for the diagnosis of type 1 diabetes in children with diabetic ketoacidosis between 2006 and 2016?
Time of Update: 2020-09-22
Data from DKA (age, sex, date of diagnosis of diabetes, ethnic minority status) from Australia, Austria, Czech Republic, Denmark, Germany, Italy, Luxembourg, New Zealand, Norway, Slovenia, Sweden, United States and United Kingdom (Wales).
The 6th Adamu monotonica biosimilar! Mylan/Concord Kirin Hulio has been approved by the U.S. FDA and will be available in 2023!
Time of Update: 2020-07-17
July 11, 2020 // Mylan and partner Fujifilm Kyowa Kirin have jointly announced that the U.S. Food and Drug Administration (FDA) has approved Hulio, amumuab-fkjp, a superweight product from AbbVie.
Measles deaths in Africa plummeted by 91% between 2000 and 2006
Time of Update: 2020-07-06
between 2,000 and 2006, the estimated number of measles deaths in Africa decreased from 396,000 to 36,000, a decrease of 91 per cent, four years ahead of the United Nations target of reducing measles deaths by 90 per
Predictive value of eGEd oedcognitive decline after deep brain electrical stimulation
Time of Update: 2020-06-29
The preoperative EEG changes were evaluated by GTE short scoring and total scoring, and mmSE, DemTect, and Mattis' dementia assessment scale were used to determine postoperative cognitive function.
Global drug market sales of more than $1.5 trillion in 2023, China's pharmaceutical industry is moving towards a "global new"
Time of Update: 2020-02-05
Pharmaceutical Network Market Analysis: Due to various factors, the global pharmaceutical industry has achieved rapid development, at the same time, the global pharmaceutical market has also been developed. According to the statistics, the global
In 2006, Alnylam became one of the top five biotechnology companies in the world to demonstrate the research and development of new RNAi drugs
Time of Update: 2019-11-24
In the field of RNAi new drug development, Alnylam pharmaceuticals is a "star company" of great concern
In 2018, the company's onpattro (paisiran) became the first FDA
Nowhere to buy it! MSD HPV vaccine Gardasil will not meet global demand until 2023
Time of Update: 2019-11-01
Until 2023, MSD's manufacturing plants will be able to fully meet the global demand for Gardasil, the HPV vaccine
What if there's no supply? MSD has started to borrow
Construction coatings market expected to reach $82.4 billion by 2023
Time of Update: 2019-04-11
The study points out that the global building coatings market is growing at a high rate due to increased demand for applications in the Asia-Pacific region and the drivers of technological innovation.
The construction coating market is expected to reach 82.4 billion US dollars by 2023
Time of Update: 2019-04-11
Population growth and economic growth in the Asia Pacific region are the main factors driving the development of building coatings market.
Global ADC treatment market will increase to 4 billion US dollars in 2023
Time of Update: 2018-10-19
In particular, CMO (contract production business) and cdmo (contract production R & D business) should take full advantage of the growing opportunities of this therapeutic product
It is found that α - eg can increase the collagen content of dermis and play a role in skin beauty
Time of Update: 2017-12-05
According to the research of Professor Kenji Oshima of Jinwa University of technology in Japan, the sweet ingredient α - eg contained in pure rice wine can increase the collagen
Ddp-4 imitation war is not ready: a large number of generic drugs will be on the market by 2023
Time of Update: 2016-11-02
Jiangsu Hengrui's class 1.1 new drug, repagliptin phosphate tablets, was the most likely drug to break the monopoly situation of foreign enterprises in ddp-4 inhibitors, but it finally withdrew its production application in 2016 and restarted phase I clinical trials.
10 years' sacrifice of 2006 drug registration and verification Massacre
Time of Update: 2016-07-22
Today is the first anniversary of the 7.22 clinical trial verification
There are many articles reviewing and reflecting on this year
Today, let's go further
CDE Electronic Journal: complete clinical trial guidance document 2006-2016
Time of Update: 2016-05-19
Clinical trial refers to the biological scientific research conducted by human volunteers, also known as subjects
Depending on the purpose of the trial, the subjects may
Global data: the global AIDS treatment market will reach 15.3 billion in 2023
Time of Update: 2015-09-28
Source: Xinkangjie 2015-9-25 global data said in the latest report that although the whole AIDS market capacity will not change greatly in the next few years, the AIDS therapy
In 2006-2014, the performance trend of pharmaceutical listed companies was disclosed!
Time of Update: 2015-07-10
Source: according to the opinion of the 2015 evaluation expert group, the Southern Institute of pharmaceutical economics defined the listed enterprises whose income from production